Lathem Family Farms' shell eggs are adulterated; FDA found a resident Salmonella Enteritidis strain and shell egg rule violations.
What happened
FDA inspected Lathem Family Farms' shell egg farm and egg processing facility from April 17, 2023, through April 21, 2023, and collected environmental swabs from poultry houses. Swabs from five houses were positive for Salmonella Enteritidis, and FDA's DNA comparison matched these to isolates from 2019 and 2021 and to a sample from a sick person in 2023. FDA also observed holes and gaps in poultry houses, animals and rodents, debris, and spilled feed, and said the company did not implement its Salmonella prevention plan.
What FDA found
The company did not have and implement a written Salmonella Enteritidis prevention plan with all required measures.
21 CFR 118.4The biosecurity plan did not include required measures to keep stray poultry, cats, and other animals out of the poultry houses.
21 CFR 118.4(b)(4)The company did not fully clean and disinfect houses after positive Salmonella Enteritidis tests before placing new flocks, and did not verify cleaning with environmental swabs.
21 CFR 118.4(d)The company did not remove debris and vegetation around poultry houses that can harbor pests; investigators saw spilled feed, flies, a dead rodent, and a storage house filled with equipment and trash.
21 CFR 118.4(c)(3)
What FDA wants
FDA asks the company to respond in writing within 15 working days with the specific steps taken to correct the violations, an explanation of how recurrence will be prevented, and related documentation. If corrections cannot be completed in that time, the company must state why and give a completion timeframe.
Who should pay attention
- retailers and distributors that sell shell eggs
- food service operators that use shell eggs
- brands that buy eggs from this farm or its breaker
This is a summary. Read the original letter on fda.gov.